期刊文献+

^(99m)Tc-MIBI乳腺肿瘤显像与组织病理学关系的初步评价 被引量:2

Relationship the ^(99m)Tc-MIBI Imaging and the Histopathologic of Breast Tumors
下载PDF
导出
摘要 目的 为探讨99mTc -甲氧基异丁基异腈 (MIBI)诊断乳腺肿瘤的临床价值及其不同组织病理学特点显像特征。方法 对 12 5例患乳腺肿物病人进行99mTc -MIBI动态多相显像及半定量分析 ,计算储留指数。结果 乳腺肿块显像特点随组织病理学类型不同有明显差别。此法检出乳腺癌的灵敏度与特异性分别为 90 %与 87%。结论 99mTc -MIBI是术前筛选和鉴别乳腺良恶性病变较好的方法 ,但对低密度癌细胞的肿瘤 。 Objective Purpose to evaluate the value of 99m Tc-MIBI imaging in the detection of breast tumors and to assess the relationship between the histopathologic features of the lesions and their imaging characteristics. Methods 125 patients with breast tumor were examined by 99m Tc-MIBI multiphase imaging and semi-quantitative analysis was performed and the retention index was calculated. Results The histopathologic features of the lesions greatly influenced with breast tumor imaging characteristics. The diagnostic sensitvity,specificity were 90% and 87%,respectively. Conclusion 99m Tc-MIBI breast imaging is a good method for preoperative screening and malignancy differentiation in breast tumors,but false negatives may occur in certain lesions with poor conditions of casualty and cellularity. [
出处 《中国医学影像技术》 CSCD 北大核心 2000年第8期666-667,共2页 Chinese Journal of Medical Imaging Technology
关键词 乳腺肿瘤 腈类 病理学 放射性核素显像 Breast neoplasms Nitriles Pathology Radionuclide imaging
  • 相关文献

参考文献3

二级参考文献1

共引文献1

同被引文献11

  • 1Mateos JJ, Vidal S, Munoz M, el al. Scintigraphic evolution of a breast cancer with ^99Tc^m- MIBI scintimammography. Clin Nucl Med,2000,25(9):701-703.
  • 2Compeau TK, Kronemer AK, Sutherlan MC. Concordant uptake of ^99mTc-sestamibi and 201 T1 in unsuspected breast tumor. J Nucl Med,1992,17:936-937.
  • 3Piwniaca Worms D, Kronange JF, Chiu ML. Uptake and retention of hexakis (2- methoxy isobutyl isonitrile) technetium (I) in cultured chick myocardial cells:mitochondria and plasma membrane potential dependence. Circulation,1990,82:1826-1838.
  • 4Sampalis FS, Denis R, Picard D, el al. International prospective evaluation of scintimammography with (99re)technetium sestamibi. Am J Surg. 2003,185(6):544-9.
  • 5Maublant JC, Zhang Z, Rapp M, et al. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi ang thallium- 201. J Nucl Med, 19,93, 34:1949-1952.
  • 6Del Vecchio S, Ciarmiello A, Pace I., et al. Fractional retention of technetium- 99m- scstimibi as an index of P-glycoprotein expression untrealed breast cancer padents. J Nucl Med, 1997,38( 9 ) : 1.348-1351.
  • 7Taillefer R, Robidoux A, Turpin S, el al. Metastatic axillary lymph node ^99Tc^m- MIBI imaging in primary breast cancer. J Nucl Med,1998,39:459-464.
  • 8Lam WW, Yang WT, Stewart IE, et al. Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breasl scintigraphy , ultrasound and conventional mammography. Eur J Nucl Med,1996,23(5):198-503.
  • 9唐军,吴锦昌,刘增礼.^(99)Tc^m-MIBI乳房亲肿瘤显像诊断原发性乳腺癌及腋淋巴结转移[J].中华核医学杂志,2000,20(3):124-126. 被引量:20
  • 10朱爱芝,陈丽蓉,郭振泉,郭秋菊,王祥云.肿瘤细胞^(99)Tc^m-MIBI和^(99)Tc^m-tetrofosmin摄取量与P-糖蛋白表达水平的关系[J].中华核医学杂志,2000,20(6):266-268. 被引量:9

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部